Prevalence of diabetes mellitus in a Saudi community

Khalid A Alqurashi, Khalid S Aljabri, Samia A Bokhari, Khalid A Alqurashi, Khalid S Aljabri, Samia A Bokhari

Abstract

Background and objectives: Quantifying the prevalence of diabetes mellitus is important to allow for rational planning and allocation of resources. Therefore, we designed this study to determine the prevalence of diabetes among Saudi nationals.

Design and setting: A cross-sectional study among patients attending a primary care clinic in June 2009.

Patients and methods: Patients were interviewed with structured questionnaires to determine the presence of diabetes by questioning for history of the disease, and charts were reviewed to document any diabetic therapies that the patients may have undergone in the past or were undergoing at that time.

Results: Of 6024 subjects, diabetes mellitus was present in 1792 (30%) patients. The mean (SD) age of the patients was 55.3 (13.2) years. The prevalence of diabetes was 34.1% in males and 27.6% in females (P<.0001). The mean (SD) age for onset of diabetes in males and females was 57.5 (13.1) and 53.4 (13.1) years, respectively (P<.0001). Females <50 years old had a higher prevalence than males in the corresponding age range-34.1% and 25.1%, respectively (P<.0001). The prevalence of diabetes decreased in patients older than 70 years. The prevalence of body mass index of ≥25 was 72.5%. Among patients with diabetes, the prevalence of body mass index of ≥25 was 85.7% (P<.0001). There was a higher prevalence of obesity (body mass index, ≥25) in females (87.7%) as compared to males (83.1%) (P=.008).

Conclusion: The prevalence of diabetes is high among the Saudi population and represents a major clinical and public health problem. A national prevention program to prevent diabetes and address the modifiable risk factors at the community level, targeting high-risk groups, should be implemented soon.

Figures

Figure 1
Figure 1
Prevalence of diabetes in groups with various ranges of body mass index.
Figure 2
Figure 2
Epidemiological studies of the prevalence of diabetes in Saudi Arabia, 1982-2009.

References

    1. Wild S, Roglic G, Green A, Kng H. Global prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
    1. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS. A Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004;25:1603–10.
    1. Elhadd TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: A review. Ann Saudi Med. 2007;4:241–50.
    1. International Diabetes Federation: Diabetes Atlas 2003. Brussels: International Diabetes Federation; 2003.
    1. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet. 2007;369:750–6.
    1. Zimmet P, Alberti KG, Shaw J. Global and societal-implications of the diabetes epidemic. Nature. 2001;414:782–7.
    1. Hamadeh RR. Noncommunicable diseases among the Bahraini population: A review. East Mediterr Health J. 2000;6:1091–7.
    1. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med. 2002;19:954–7.
    1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723–7.
    1. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9.
    1. Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JP, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: Association with cardiovascular risk factors. Postgrad Med J. 2006;82:280–4.
    1. Wells JC. A Hattori chart analysis of body mass index in infants and children. Int J Obes Relat Metab Disord. 2000;24:325–9.
    1. Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–9.
    1. Williams PT, Hoffman K, La I. Weight-related increases in hypertension, hypercholesterolemia, and diabetes risk in normal weight male and female runners. Arterioscler Thromb Vasc Biol. 2007;27:1811–9.
    1. Al-Turki Y. The prevalence of overweight and obesity amongst hypertensive and diabetic adult patients in primary health care. Saudi Med J. 2000;21:340–3.
    1. El-Hazmi MA, Warsy AS. Prevalence of overweight and obesity in diabetic and non-diabetic Saudis. East Mediterr Health. 2000;6:276–82.
    1. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
    1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
    1. Al-Riyami A, Afii Mi. Accuracy of self-reporting of diabetes mellitus and hypertension and its determinants among Omani adults. Saudi Med J. 2003;24:1025–6.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren